Coeptis Therapeutics Competitors and Similar CompaniesClear all
Coeptis Therapeutics's competitors and similar companies include Seagen, Mallinckrodt Pharmaceuticals, Opsy and Legend Biotech.
 Coeptis Therapeutics Coeptis Therapeutics (also known as Coeptis Therapeutics Holdings) is a biopharmaceutical company that specializes in cancer treatment solutions. |  Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer. |  Mallinckrodt Pharmaceuticals Mallinckrodt is a business that develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products and therapies. |  Opsy Opsy Holding (formerly WntResearch) is a biotech company that develops therapies for preventing cancer spread. |  Legend Biotech Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications.
| |
Founding Date | Founding Date 2017 | Founding Date 1998 | Founding Date 1867 | Founding Date 2007 | Founding Date 2014 |
Type | Type Public | Type Subsidiary | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations HQ | Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more | Locations Dublin 15, IE HQ Staines, GB Hazelwood, US Webster Groves, US | Locations Gothenburg, SE HQ Lund, SE | Locations Somerset, US HQ Ghent, BE Nanjing, CN Hong Kong, HK Dublin, IE Piscataway, US |
Employees | Employees N/A | Employees 3,25622% increase | Employees 3,373 | Employees 2 | Employees 2,90012% increase |
Valuation ($) | Valuation ($) 8.3 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 721.5 k | Valuation ($) 8.4 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $2b (FY, 2022) | Revenue (est.) $1b (FY, 2022) | Revenue (est.) kr6.7m (FY, 2025) | Revenue (est.) $1b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $410.1m (FY, 2022) | Cost of goods $643.5m (FY, 2022) | Cost of goods kr1.3m (FY, 2025) | Cost of goods $408.1m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $1.6b (FY, 2022) | Gross profit $396.2m (FY, 2022) | Gross profit kr5.4m (FY, 2025) | Gross profit $620.8m (FY, 2025) |
Net income | Net income N/A | Net income ($610.3m) (FY, 2022) | Net income ($598.3m) (FY, 2022) | Net income (kr17.2m) (FY, 2025) | Net income ($296.8m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 164m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 150.5m |
For sources of this data, please see the company profile
View Company Profiles
Seagen
HQ
Bothell, US
Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.
View companyMallinckrodt Pharmaceuticals
HQ
Dublin 15, IE
Employees
3,373
Mallinckrodt is a business that develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products and therapies.
View companyOpsy
HQ
Gothenburg, SE
Employees
2
Opsy Holding (formerly WntResearch) is a biotech company that develops therapies for preventing cancer spread.
View companyLegend Biotech
HQ
Somerset, US
Employees
2,900↑ 12% increase
Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications.
View company